ABL Diagnostics Announces Strategic AI Roadmap to Advance Molecular Research and Global Data Security
WOIPPY, FRANCE, May 18, 2026 /EINPresswire.com/ -- ABL Diagnostics (FR001400AHX6 – “ABLD”), a specialist in molecular diagnostics, bioinformatics and infectious disease solutions, today announces its strategic commitment to integrating Artificial …